Gilead Sciences Inc.
Gilead Sciences Inc. logo
GILD

Gilead Sciences Inc. (GILD)

$85.830.5%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$85.63
Day's Range
$88.0841
$55.27
52-Week Range
$86.41
1 month return8.82%
3 month return38.13%
1 year return22.09%
5 year return18.83%

Company Information

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead has promoted equity, particularly healthcare equity, since the company brought its first therapies to the market. Through global partnerships, Gilead's medicines today reach millions of people in low- and middle-income countries around the world. In the United States, Gilead has committed more than $100 million over 10 years through the COMPASS Initiative to community organizations that are working to combat HIV in the Southern United States. In 2020, Gilead launched the Racial Equity Community Impact Fund to support organizations tackling racial inequities affecting Black communities across the United States.
OrganizationGilead Sciences Inc.
Employees14400
CEOMr. Daniel P. O'Day
IndustryHealth Technology

Analyst Recommendation

based on 29 analysts ratings

Hold
44%
Buy
51%
Hold
3%
Sell

Based on 29 Wall street analysts offering stock ratings for Gilead Sciences Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Downside of 5.66%

Current

$86.0

Target

$81.13

Recommendation Trend

Based on 29 analyst

Current1M Ago3M Ago
Buy
13
16
15
Hold
15
20
21
Sell
1
1
1
Consensus
HOLD
HOLD
HOLD

Highlights

Market Capitalization
107.1B
Book Value
$16.81
Dividend Share
2.9
Dividend Yield
3.4000000000000004%
Earnings Per Share (EPS)
2.64
PE Ratio
32.36
PEG Ratio
0.69
Wall Street Target Price
81.13

Valuation

Trailing PE32.36
Forward PE12.69
Price/Book (mrq)
4.98
Enterprise Value
124.4B
Enterprise Value/Revenue
4.59
Enterprise Value/Ebitda
22.67

Technicals

Beta
0.44
50 Day MA
71.69
200 Day MA
64.3

Sustainability

Rating Date2019-01-01
Total Esg
22.15
Total Esg Percentile
30.98
Environment Score0.53
Environment Score Percentile2.0
Social Score12.97
Social Score Percentile2.0
Governance Score7.65
GovernanceScorePercentile2.0
Controversy Level2.0

Institutional Holdings

Vanguard Group Inc

8.8%

State Street Corporation

4.62%

Capital Research Global Investors

4.46%

Capital World Investors

4.21%

Dodge & Cox

2.95%

Geode Capital Management, LLC

1.85%

Discover more

Frequently Asked Questions

What is Gilead Sciences Inc. share price today?

Can Indians buy Gilead Sciences Inc. shares?

How can I buy Gilead Sciences Inc. shares from India?

Can Fractional shares of Gilead Sciences Inc. be purchased?

What are the documents required to start investing in Gilead Sciences Inc. stocks?

What are today’s High and Low prices of Gilead Sciences Inc.?

What are today’s traded volumes of Gilead Sciences Inc.?

What is today’s market capitalisation of Gilead Sciences Inc.?

What is the 52 Week High and Low Range of Gilead Sciences Inc.?

How much percentage Gilead Sciences Inc. is down from its 52 Week High?

How much percentage Gilead Sciences Inc. is up from its 52 Week low?

What are the historical returns of Gilead Sciences Inc.?

Who is the Chief Executive Officer (CEO) of Gilead Sciences Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*